Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Henrike Karim- Kos

Group leader, Epidemiologist

Childhood Cancer Epidemiology & Outcomes

Phone +31618418717

Henrike Karim-Kos is a cancer epidemiologist with a PhD degree from Erasmus University Rotterdam, the Netherlands (2012). Her PhD was focused on measuring progress against cancer in the Netherlands since the late 1980s using population-based data on incidence, prognosis and mortality. During her PhD, she was also a member of an expert committee for the Dutch Cancer Society which resulted in a report on future projections of incidence, mortality, and prevalence. Before her PhD, she did her Masters in Human Nutrition & Epidemiology at the Wageningen University & Research, the Netherlands (2003), and worked as a researcher on various projects focused on improving quality of care for cancer patients at the Netherlands Comprehensive Cancer Organisation (IKNL). After completion of her PhD, she worked as a consultant researcher at the International Atomic Energy Agency (IAEA), Vienna, Austria on the ‘Programme of Action for Cancer Therapy’ and later as a researcher at the Austrian National Cancer Registry (ANCR), Vienna, Austria. At the ANCR, she set up epidemiological research for childhood cancer in close collaboration with pediatric oncologists from St. Anna Children’s Hospital, Vienna and Medical University of Vienna.

Currently, she is appointed as principal investigator for Childhood Cancer Epidemiology & Outcomes at the Princess Máxima Center for pediatric oncology, and also as a senior researcher at the Netherlands Comprehensive Cancer Organisation (IKNL).

  • Corrigendum to “Comparative analysis of 5-year relative survival in adolescents and young adults with cancer relative to both children and adults in Europe (EUROCARE-6)

    • okt. 2025
    • , et al
    • European Journal of Cancer
  • 5-Year conditional relative survival of adolescents and young adults with solid malignancies in the Netherlands

    • okt. 2025
    • Noelle J.M.C., Vrancken Peeters, et al
    • The Lancet Regional Health - Europe
  • Comparative analysis of 5-year relative survival in adolescents and young adults with cancer relative to both children and adults in Europe (EUROCARE-6)

    • aug. 2025
    • , et al
    • European Journal of Cancer
  • Long-term survival and cure fraction estimates for paediatric central nervous system tumours in 31 European countries (EUROCARE-6)

    • aug. 2025
    • , et al
    • The Lancet Oncology
  • Survival of European children, adolescents and young adults diagnosed with haematological malignancies in the period 2000–2013

    • jun. 2025
    • A., Trama, et al
    • European Journal of Cancer
View all publications